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n MDM2 and MDMX bind and
stabilize the p53-related
protein p73
Weg M Ongkeko, Xiao Qi Wang,
Wai Yi Siu, Anita WS Lau,
Katsumi Yamashita, Adrian L Harris,
Lynne S Cox, Randy YC Poon
(1999). Curr. Biol. 9, 829–832.
The p53 gene encodes one of the most
important tumor suppressors in human
cells and undergoes frequent mutational
inactivation in cancers. MDM2,
a transcriptional target of p53, binds p53
and can both inhibit p53-mediated
transcription and target p53 for
proteasome-mediated proteolysis. A
close relative of p53, p73, has recently
been identified. The authors report
that, like p53, p73α and the alternative
transcription product p73β also bind
MDM2. Interaction between MDM2
and p53 represents a key step in the
regulation of p53, as MDM2 promotes
the degradation of p53. In striking
contrast to p53, the half-life of p73 was
found to be increased by binding to
MDM2. Like MDM2, the MDM2-
related protein MDMX also bound p73
and stabilized the level of p73.
Moreover, the growth suppression
functions of p73 and the induction of
endogenous p21, a major mediator of
the p53-dependent growth arrest
pathway, were enhanced in the presence
of MDM2. These differences between
the regulation of p53 and p73 by
MDM2/MDMX may highlight a
physiological difference in their action. 
26 July 1999, Brief Communication,
Current Biology. 
n The Akt kinase signals directly
to endothelial nitric oxide
synthase
BJ Michell, JE Griffiths, KI Mitchelhill,
I Rodriguez-Crespo, T Tiganis, S
Bozinovski, PR Ortiz de Montellano,
BE Kemp, RB Pearson (1999).
Curr. Biol. 9, 845–848.
Endothelial nitric oxide synthase
(eNOS) is an important modulator of
angiogenesis and vascular tone. It is
stimulated by treatment of endothelial
cells in a phosphatidylinositol 3-kinase
(PI 3-kinase)-dependent fashion by
insulin-like growth factor-1 (IGF-1) and
vascular endothelial growth factor
(VEGF) and is activated by
phosphorylation at Ser1177 in the
sequence RIRTQS1177F. The protein
kinase Akt is an important downstream
target of PI 3-kinase, regulating VEGF-
stimulated endothelial cell survival. Akt
phosphorylates substrates within a
defined motif, which is present in the
sequence surrounding Ser1177 in
eNOS. Both Akt and eNOS are
localized to, and activated at, the plasma
membrane. The authors found that
purified Akt phosphorylated cardiac
eNOS at Ser1177, resulting in activation
of eNOS. Phosphorylation at this site
was stimulated by treatment of bovine
aortic endothelial cells (BAECs) with
VEGF or IGF-1, and Akt was activated
in parallel. Preincubation with
wortmannin, an inhibitor of Akt
signalling, reduced VEGF- or IGF-1-
induced Akt activity and eNOS
phosphorylation. Akt was detected in
immunoprecipitates of eNOS from
BAECs, and eNOS in
immunoprecipitates of Akt, indicating
that the two enzymes become
associated in vivo. These results strongly
suggest that Akt has an important role in
the regulation of normal angiogenesis
and raise the possibility that the
enhanced activity of this kinase that
occurs in carcinomas might contribute to
tumor vascularization and survival.
26 July 1999, Brief Communication,
Current Biology. 
n The trace amine tyrosine is
essential for sensitization to
cocaine in Drosophila
Colleen McClung, Jay Hirsch
(1999). Curr. Biol. 9, 853-860.
Sensitization to psychostimulant drugs
of abuse is thought to be an important
aspect of human addiction, yet how it
develops is still unclear. How
sensitization to cocaine develops in the
the fruit fly Drosophila melanogaster is
strikingly similar to that observed in
vertebrates. By taking advantage of the
powerful genetic approaches that are
possible in Drosophila, the authors were
able to identify and characterize
mutants that fail to develop
sensitization. They found that the
Drosophila mutant inactive (iav) failed to
become sensitized to cocaine. Mutant
flies had reduced amounts of the trace
amine tyramine in the brain because of
reduced activity of the enzyme tyrosine
decarboxylase (TDC), which converts
tyrosine to tyramine. Furthermore,
cocaine exposure induced TDC enzyme
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activity in a time-dependent manner
that paralleled the development of
behavioral sensitization. The
sensitization failure of iav flies could be
rescued by feeding the flies with
tyramine; other biogenic amines or
amine precursors did not have the same
effect. These results indicate an
essential role for tyramine in cocaine
sensitization in Drosophila.
30 July 1999, Research Paper, Current
Biology. 
n Imaging Ca2+ concentration
changes at the secretory vesicle
surface with a recombinant
targeted cameleon
Evaggelia Emmanouilidou, Anja G
Teschemacher, Aristea E Pouli,
Linda I Nicholls, Elizabeth P
Seward, Guy A Rutter (1999).
Curr. Biol. 9, 915–918.
Regulated exocytosis involves the Ca2+-
triggered fusion of secretory vesicles with
the plasma membrane, by activation of
vesicle membrane Ca2+-binding proteins.
The Ca2+-binding sites of these proteins
are likely to lie within 30 nm of the
vesicle surface, a domain in which
changes in Ca2+ concentration cannot be
resolved by conventional fluorescence
microscopy. A fluorescent indicator for
Ca2+ called a yellow ‘cameleon’
(Ycam2) — comprised of a fusion
between a cyan-emitting mutant of the
green fluorescent protein (GFP),
calmodulin, the calmodulin-binding
peptide M13 and an enhanced yellow-
emitting GFP — which can be targetted
to specific intracellular locations, has
been described previously. Here, the
authors generated a fusion between
phogrin, a protein that is localised to
secretory granule membranes, and
Ycam2 (phogrin–Ycam2) to monitor
changes in Ca2+ concentration ([Ca2+]) at
the secretory vesicle surface ([Ca2+]gd)
through alterations in fluorescence
resonance energy transfer (FRET)
between the linked cyan and yellow
fluorescent proteins (CFP and YFP,
respectively) in Ycam2. In both
neuroendocrine PC12 and MIN6
pancreatic β cells, apparent resting values
of cytosolic [Ca2+] and [Ca2+]gd were
similar throughout the cell. In MIN6
cells following the activation of Ca2+
influx, the minority of vesicles that were
within ~1 µm of the plasma membrane
underwent increases in [Ca2+]gd that
were significantly greater than those
experienced by deeper vesicles, and
greater than the apparent cytosolic [Ca2+]
change. The ability to image both global
and compartmentalised [Ca2+] changes
with recombinant targeted cameleons
should extend the usefulness of these
new Ca2+ probes.
16 August 1999, Brief Communication,
Current Biology. 
n Drosophila grapes/CHK1
mutants are defective in cyclin
proteolysis and coordination of
mitotic events
Tin Tin Su, Shelagh D Campbell,
Patrick H O’Farrell (1999).
Curr. Biol. 9, 919–922.
The Drosophila grapes (grp) gene, which
encodes a homolog of the
Schizosaccharomyces pombe Chk1 kinase,
provides a cell-cycle checkpoint that
delays mitosis in response to inhibition
of DNA replication. Grp is also required
in the undisturbed early embryonic
cycles: in its absence, mitotic
abnormalities appear in cycle 12 and
chromosomes fail to fully separate in
subsequent cycles. In other systems,
Chk1 kinase phosphorylates and
suppresses the activity of Cdc25
phosphatase: the resulting failure to
remove inhibitory phosphate from
cyclin-dependent kinase 1 (Cdk1)
prevents entry into mitosis. Because in
Drosophila embryos Cdk1 lacks
inhibitory phosphate during cycles
11–13, it is not clear that known actions
of Grp/Chk1 suffice in these cycles.
The authors found that the loss of grp
compromised cyclin A proteolysis and
delayed mitotic disjunction of sister
chromosomes. These defects occurred
before previously reported grp
phenotypes. The authors conclude that
Grp activates cyclin A degradation, and
functions to time the disjunction of
chromosomes in the early embryo. As
cyclin A destruction is required for sister
chromosome separation, a failure in
Grp-promoted cyclin destruction can
also explain the mitotic phenotype. The
mitotic failure described previously for
cycle 12 grp embryos might be a more
severe form of the phenotypes that we
describe in earlier embryos and we
suggest that the underlying defect is
reduced degradation of cyclin A. 
16 August 1999, Brief Communication,
Current Biology. 
n Specific inhibition of insect
α-amylases: yellow meal worm
α-amylase in complex with the
Amaranth α-amylase inhibitor at
2.0 Å resolution
Pedro José Barbosa Pereira,
Valentin Lozanov, András Patthy,
Robert Huber, Wolfram Bode,
Sándor Pongor, Stefan Strobl
(1999). Structure 7, 1079–1088.
α-Amylases constitute a family of
enzymes that catalyze the hydrolysis of
α-D-(1,4)-glucan linkages in starch and
related polysaccharides. The Amaranth
α-amylase inhibitor (AAI) specifically
inhibits insect α-amylases. AAI is the
smallest proteinaceous α-amylase
inhibitor described so far and has no
known homologs in the sequence
databases. Its mode of inhibition of
α-amylases was unknown until now.
The crystal structure of yellow meal
worm α-amylase (TMA) in complex
with AAI was determined. The overall
fold of AAI identifies it as a knottin-
like protein. The inhibitor binds to the
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active-site groove of TMA, blocking
the central four sugar-binding subsites.
The binding of AAI to TMA presents a
new inhibition mode for α-amylases.
Because of its unique specificity
towards insect α-amylases, AAI could
be a valuable tool for protecting crop
plants against predatory insects. The
close structural homology between AAI
and ‘knottins’ opens new perspectives
for the engineering of various novel
activities onto the small scaffold of this
group of proteins.
26 August 1999, Research Paper,
Structure. 
n The three-dimensional structure
of caspase-8: an initiator
enzyme in apoptosis
Helen Blanchard, Lalitha
Kodandapani, Peer RE Mittl,
Stefania Di Marco, Joseph F Krebs,
Joe C Wu, Kevin J Tomaselli, Markus
G Grütter (1999). Structure
7, 1125–1133.
In the initial stages of Fas-mediated
apoptosis the cysteine protease
caspase-8 is recruited to the cell
receptor as a zymogen (procaspase-8)
and is incorporated into the death-
signalling complex. Procaspase-8 is
subsequently activated leading to a
cascade of proteolytic events, ultimately
resulting in cell death. Variations in the
substrate specificity of different
caspases have been reported. The
authors report here the crystal structure
of a complex of the activated human
caspase-8 (proteolytic domain) with the
irreversible peptidic inhibitor
Z-Glu–Val–Asp-dichloromethylketone.
This is the first structure of a
representative of the long prodomain
initiator caspases and of the group III
substrate specificity class. The overall
protein architecture resembles the
caspase-1 and caspase-3 folds, but shows
distinct structural differences in regions
forming the active site. In particular,
differences observed in subsites S3, S4
and the loops involved in inhibitor
interactions explain the preference of
caspase-8 for substrates with the
sequence (Leu/Val)–Glu–X–Asp. The
structural differences were correlated
with the observed substrate specificities
of caspase-1, caspase-3 and caspase-8, as
determined from kinetic experiments.
This information will help us to
understand the role of the various
caspases in the propagation of the
apoptotic signal, and should be useful
for the design of specific inhibitors.
27 August 1999, Research Paper,
Structure. 
n The atomic-resolution structure
of human caspase-8, a key
activator of apoptosis
William Watt, Kenneth A Koeplinger,
Ana M Mildner, Robert L Heinrikson,
Alfredo G Tomasselli, Keith D
Watenpaugh (1999). Structure
7, 1135–1143.
Caspases are a family of cysteine
proteases that play important
intracellular roles in inflammation and
apoptosis. Caspase-8 activates
downstream caspases that are unable to
carry out autocatalytic processing and
activation. Caspase-8 is designated an
initiator caspase and is believed to sit at
the apex of the Fas- or TNF-mediated
apoptotic cascade. In light of this role,
the enzyme is an attractive target for the
design of inhibitors aimed at blocking
the undesirable cell death associated
with a range of degenerative disorders.
The structure of recombinant human
caspase-8, covalently modified with the
inhibitor acetyl-Ile–Glu–Thr–Asp-
aldehyde, has been determined. The
asymmetric unit contains the p18–p11
heterodimer; the biologically important
molecule contains two dimers. The
overall fold is very similar to that of
caspase-1 and caspase-3, but significant
differences exist in the substrate-binding
region. The structure answers questions
about the enzyme–inhibitor complex
that could not be explained from earlier
caspase structures solved at lower
resolution. The caspase-8–inhibitor
structure provides the basis for
understanding structure/function
relationships in this important initiator of
the proteolytic cascade that leads to
programmed cell death.
27 August 1999, Research Paper,
Structure. 
n Folding studies of
immunoglobulin-like β-sandwich
proteins suggest that they share
a common folding pathway
Jane Clarke, Ernesto Cota, Susan B
Fowler, Stefan J Hamill (1999).
Structure 7, 1145–1153.
Are folding pathways conserved in
protein families? To test this explicitly
and ask to what extent structure
specifies folding pathways requires
comparison of proteins with a common
fold. The authors chose to examine
members of a highly diverse protein
family with no conservation of function
R288 Chemistry & Biology 1999, Vol 6 No 10
and little or no sequence identity, but
with structures that are essentially the
same. The immunoglobulin-like fold is
one of the most common structural
families, and is subdivided into
superfamilies with no detectable
evolutionary or functional relationship.
The folding of a number of
immunoglobulin-like proteins that have
a common structural core were
compared and a strong correlation
between folding rate and stability was
found. The results suggest that the
folding pathways of these
immunoglobulin-like proteins share
common features. This study is the first
to compare the folding of structurally
related proteins that are members of
different superfamilies. The most likely
explanation for the results is that
interactions that are important in
defining the structure of
immunoglobulin-like proteins are also
used to guide folding.
31 August 1999, Research Paper,
Structure. 
n X-ray crystal structure of
aminoimidazole ribonucleotide
synthetase (PurM), from the
Escherichia coli purine
biosynthetic pathway at 2.5 Å
resolution
Chenglong Li, T Joseph Kappock,
JoAnne Stubbe, Todd M Weaver,
Steven E Ealick (1999). Structure
7, 1155–1166.
Eleven enzymes are involved in the
procaryotic purine biosynthetic pathway,
six of which use ATP. Enzymes 5 and 6
of this pathway, formylglycinamide
ribonucleotide (FGAR)
amidotransferase (PurL) and
aminoimidazole ribonucleotide (AIR)
synthetase (PurM) use ATP to activate
the oxygen of an amide within their
substrate toward nucleophilic attack by
a nitrogen. AIR synthetase uses the
product of PurL, formylglycinamidine
ribonucleotide (FGAM) and ATP to
make AIR, ADP and Pi. The structure
of a hexahistidine-tagged PurM has
been solved, and the final model of
PurM consists of two
crystallographically independent dimers
and four sulfates. The active site,
identified in part by conserved residues,
is proposed to be a long groove
generated by the interaction of two
monomers. A search of the sequence
databases suggests that the
ATP-binding sites between PurM and
PurL may be structurally conserved.
Sequence searches suggest that two
successive enzymes in the purine
biosynthetic pathway, proposed to use
similar chemistries, will have similar
ATP-binding domains.
1 September 1999, Research Paper,
Structure.
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